MedTrace Logo

Augmentation of Screening Colonoscopy With Fecal Immunochemical Testing

NCT00892593 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4100

Last updated 2014-07-21

No results posted yet for this study

Summary

The study will determine if adding fecal immunochemical testing (FIT) at yearly intervals to a colonoscopy screening program will improve colon cancer detection rates.

Conditions

Interventions

DEVICE

Fecal Immunochemical Testing

Fecal Immunochemical Testing is a stool test specific for human hemoglobin.

DEVICE

Fecal Immunochemical Testing

Fecal Immunochemical Testing is a stool test specific for human hemoglobin.

Sponsors & Collaborators

  • Forsyth Medical Center

    lead OTHER

Principal Investigators

  • Daniel Murphy, M.D. · Piedmont Gastroenterology Specialists

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2019-05-31
Completion
2020-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00892593 on ClinicalTrials.gov